Class / Patent application number | Description | Number of patent applications / Date published |
544239000 | Chalcogen bonded directly to ring carbon of a 1,2-diazine ring | 6 |
20120165524 | Process for Preparing Levosimendan and Intermediates for Use in the Process - In an embodiment, the present invention provides a process for preparing (−)-6-(4-aminophenyl)-5-methylpyridazin-3-(2H)-one, which process comprises: a) reacting racemic 6-(4-aminophenyl)-4,5-dihydro-5-methyl-3-(2H)-pyridazinone of formula II | 06-28-2012 |
20160060225 | METHOD OF MANUFACTURING PYRIDAZINONE COMPOUND - A compound represented by formula (2) | 03-03-2016 |
544240000 | Plural chalcogens bonded directly | 4 |
20150126738 | PYRIDAZINONE COMPOUND AND USE THEREOF - A pyridazinone compound represented by the formula (I) | 05-07-2015 |
20150126739 | PYRIDAZINONE COMPOUND AND USE THEREOF - A pyridazinone compound represented by the formula (I) | 05-07-2015 |
20160090363 | METHOD FOR PRODUCING PYRIDAZINE COMPOUND - A pyridazine compound represented by formula [1]: which is useful as an active ingredient of a plant disease control agent can be produced, by steps of obtaining a compound represented by formula [3]: by reacting a compound represented by formula [4]: with a compound represented by formula [5]: obtaining a compound represented by formula [2]: by deprotecting the compound [3]; and reacting the compound [2] with a chlorinating agent. | 03-31-2016 |
20160130235 | CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING - The present disclosure is directed, in part, to compounds and methods for imaging myocardial perfusion, comprising administering to a patient a contrast agent which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging. | 05-12-2016 |